Early Immunosuppressants in Crohn's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

December 31, 2012

Study Completion Date

June 30, 2013

Conditions
Crohn's Disease
Interventions
DRUG

early immunosuppressants (azathioprine, methotrexate)

azathioprine 2.5 mg/kg/day SC methotrexate 25 mg/week if aza not tolerated

Trial Locations (26)

13915

Chu Marseille - Hopital Nord, Marseille

14033

CHU CAEN, Caen

25030

Chu Besancon, Besançon

31403

Chu Toulouse, Toulouse

33604

Hopital Haut Leveque, Pessac

37044

Chu Tours, Tours

44093

Chu Nantes, Nantes

51092

Chu Reims, Reims

59037

Chru Lille, Lille

63003

Chu Clermont-Ferrand, Clermont-Ferrand

67091

Chu Strasbourg, Strasbourg

69495

CHU LYON, Pierre-Bénite

75010

Hopital Lariboisiere, Paris

Hopital Saint Louis, Paris

75012

Hopital St Antoine, Paris

75014

Hopital Cochin, Paris

75015

Hopital Georges Pompidou, Paris

75018

Hopital Bichat, Paris

75674

Institut Mutualiste Montsouris (Imm), Paris

76031

Chu Rouen, Rouen

80054

Chu Amiens, Amiens

92110

Hopital Beaujon, Clichy

92700

Hopital Louis Mourrier, Colombes

93370

Ch Le Raincy Montfermeil, Montfermeil

94275

Hopital Bicetre, Le Kremlin-Bicêtre

06202

CHU NICE, Nice

All Listed Sponsors
collaborator

Société Nationale Française de Gastroentérologie

OTHER

lead

Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

OTHER

NCT00546546 - Early Immunosuppressants in Crohn's Disease | Biotech Hunter | Biotech Hunter